Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Glioblastoma × Tablets × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Vomiting 1 Vascular Malformations 1 Resectable Pancreatic Ductal Adenocarcinoma 1 Prostatic Neoplasms 1 Neoplasms 1 Nausea 1 Myasthenia Gravis 1 Microbiota 1 Melanoma 1 Lymphangioma 1 Hepatitis B 1 Hand-Foot Skin Reaction (HFSR) 1 Glioblastoma 1 Erectile Dysfunction 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Temozolomide 40 Radiotherapy 15 Bevacizumab 9 Surgical Procedures, Operative 5 Carmustine 5 pembrolizumab 3 Sunitinib 3 Radiation 3 Procarbazine 3 Lomustine 3 Irinotecan 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Chlorotoxin 3 Carboplatin 3 Blood Specimen Collection 3 fludarabine 2 camrelizumab 2 Radiosurgery 2 Neoadjuvant Therapy 2 Magnetic Resonance Spectroscopy 2 Hyperbaric Oxygenation 2 Ethanol 2 Drug Therapy 2 Cyclophosphamide 2 Chemotherapy, Adjuvant 2 CT-322 2 Bortezomib 2 Aminolevulinic Acid 2 verubulin 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04772846 2021-02-26

Chloroquine for Glioblastoma.

Egyptian Medical Syndicate

Phase 1/2 Unknown

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡